Microbial DNA and other macromolecules

Microbial DNA and other macromolecules encompass the essential biological polymers—including deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins, and complex polysaccharides—that constitute the structural and functional framework of bacteria, fungi, and parasites [1]. These molecules are fundamental to the survival, replication, and virulence of pathogens, making them primary targets for various antimicrobial therapies [2]. For instance, certain antibiotics like metronidazole are activated within the microbe to form reactive intermediates that cause lethal DNA strand breaks [3]. Other agents, such as nitrofurantoin, produce reactive metabolites that attack multiple microbial macromolecules simultaneously, including ribosomal proteins and DNA [4]. The therapeutic utility of targeting these molecules relies on the biochemical differences between microbial and host macromolecules, which facilitates selective toxicity [5]. However, because this term describes a broad category rather than a single specific receptor or enzyme, it includes a wide array of pharmacological mechanisms and clinical applications [3]. Understanding these targets is crucial for developing treatments against infectious diseases and managing the ongoing challenge of antimicrobial resistance [6]. This broad targeting approach is often effective against anaerobic organisms and certain protozoa where specific metabolic pathways activate the drug [1].

Other names

Microbial nucleic acidsBacterial DNAMicrobial polymersPathogen macromoleculesBacterial macromolecules

Drugs targeting these macromolecules typically act by inducing direct chemical damage, such as DNA strand breakage via reactive intermediates, or by non-specifically binding to and disrupting the function of essential microbial polymers [1][3][4].